The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells

Oncogene

Volumn 27, Issue 7, 2008, Pages 907-917

  Engelbert, D ^a   Schnerch, D ^a   Baumgarten, A ^a   Wasch R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anaphase promoting complex; Cdh1; Genomic instability; Mitotic exit; Ubiquitin dependent proteolysis

Indexed keywords

PROTEIN P21; PROTEIN P53; UBIQUITIN LIGASE APC CDH1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UVOMORULIN;

ACCURACY; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CHROMOSOME; CYTOKINESIS; DAUGHTER CELL; DNA REPLICATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LENTIVIRINAE; MITOSIS; PRIORITY JOURNAL; RNA INTERFERENCE;

BLOTTING, WESTERN; BONE NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN A; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; G1 PHASE; GENOMIC INSTABILITY; HUMANS; KIDNEY; LENTIVIRUS; MITOSIS; OSTEOSARCOMA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; S PHASE; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITIN-PROTEIN LIGASES;

EID: 38949099707     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210703     Document Type: Article

References (46)

1. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
2. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. (2004). Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428: 190-193.
3. Brummelkamp TR, Bernards R, Agami R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
4. Carmena M, Earnshaw WC. (2003). The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4: 842-854.
5. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. (2006). A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38: 1043-1048.
6. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. (2006). The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214-217.
7. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED. (2001). Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153: 517-527.
8. Cross FR. (2003). Two redundant oscillatory mechanisms in the yeast cell cycle. Dev Cell 4: 741-752.
9. Diffley JF. (2004). Regulation of early events in chromosome replication. Curr Biol 14: R778-R786.
10. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol, 846-8471.
11. Efeyan A, Garcia-Cao I, Herranz D, Velasco-Miguel S, Serrano M. (2006). Tumour biology: policing of oncogene activity by p53. Nature 443: 159.
12. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. (2004). Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165: 789-800.
13. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
14. Hagting A, Den Elzen N, Vodermaier HC, Waizenegger IC, Peters JM, Pines J. (2002). Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1. J Cell Biol 157: 1125-1137.
15. Hahn WC, Weinberg RA. (2002). Rules for making human tumor cells. N Engl J Med 347: 1593-1603.
16. Harper JW, Burton JL, Solomon MJ. (2002). The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev 16: 2179-2206.
17. Hoeller D, Hecker CM, Dikic I. (2006). Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 6: 776-788.
18. Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM, Saunders WS. (2004). Resolution of anaphase bridges in cancer cells. Chromosoma 112: 389-397.
19. Lehman NL, Verschuren EW, Hsu JY, Cherry AM, Jackson PK. (2006). Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 5: 1569-1573.
20. Lengronne A, Schwob E. (2002). The yeast CDK inhibitor Sic1 prevents genomic instability by promoting replication origin licensing in late G1. Mol Cell 9: 1067-1078.
21. Lindon C, Pines J. (2004). Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J Cell Biol 164: 233-241.
22. Meraldi P, Honda R, Nigg EA. (2002). Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 21: 483-492.
23. Morgan D. (1999). Regulation of the APC and the exit from mitosis. Nat Cell Biol 1: E47-E53.
24. Morgenstern JP, Land H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
25. Nagao K, Adachi Y, Yanagida M. (2004). Separase-mediated cleavage of cohesin at interphase is required for DNA repair. Nature 430: 1044-1048.
26. Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K. (2004). siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res 32: W124-W129.
27. Park KH, Choi SE, Eom M, Kang Y. (2005). Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships. Breast Cancer Res 7: R238-R247.
28. Peters JM. (2006). The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7: 644-656.
29. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B et al. (2004). Inactivation of hCDC4 can cause chromosomal instability. Nature 428: 77-81.
30. Rape M, Kirschner M. (2004). Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 432: 588-595.
31. Rape M, Reddy SK, Kirschner MW. (2006). The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124: 89-103.
32. Romero F, Gil-Bernabe AM, Saez C, Japon MA, Pintor-Toro JA, Tortolero M. (2004). Securin is a target of the UV response pathway in mammalian cells. Mol Cell Biol 24: 2720-2733.
33. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J et al. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406.
34. Sigrist SJ, Lehner CF. (1997). Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles. Cell 90: 671-681.
35. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK et al. (2004). The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129-137.
36. Spruck CH, Won KA, Reed SI. (1999). Deregulated cyclin E induces chromosome instability. Nature 401: 297-300.
37. Sudo T, Ota Y, Kotani S, Nakao M, Takami Y, Takeda S et al. (2001). Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO J 20: 6499-6508.
38. Taguchi S, Honda K, Sugiura K, Yamaguchi A, Furukawa K, Urano T. (2002). Degradation of human Aurora-A protein kinase is mediated by hCdh1. FEBS Lett 519: 59-65.
39. Veelken H, Jesuiter H, Mackensen A, Kulmburg P, Schultze J, Rosenthal F et al. (1994). Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum Gene Ther 5: 1203-1210.
40. Wang CX, Fisk BC, Wadehra M, Su H, Braun J. (2000). Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood 96: 259-263.
41. Wang Q, Moyret-Lalle C, Couzon F, Surbiguet-Clippe C, Saurin JC, Lorca T et al. (2003). Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene 22: 1486-1490.
42. Wäsch R, Cross FR. (2002). APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature 418: 556-562.
43. Wäsch R, Engelbert D. (2005). Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene 24: 1-10.
44. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin Jr WG. (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1by the anaphase-promoting complex. Nature 428: 194-198.
45. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193.
46. Zur A, BrandeisM. (2001). Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO J 20: 792-801.